Botanical species · safety record

Mandragora officinalis

The EFSA Compendium of Botanicals holds 24 constituent measurements and 2 adverse-effect records for Mandragora officinalis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Mandragora officinalis Mill.

24Constituent measurements
2Safety records
6Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Alkaloids6
  • Atropine6
  • Scopolamine6
  • Benzaldehyde1
  • Calystegine b1
  • Calystegines1
  • Coumarins1
  • Eugenol1
  • Isoeugenol1

Plant parts

  • Leaves8
  • Roots and other underground parts7
  • Seed5
  • Fruit unspecified3
  • Live plants3

Preparations

  • Solvent extraction24
  • Fresh1

Effect types

  • Systemic2

Target tissues

  • Cardiovascular2
  • haematological2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Calystegine bLeavesSolvent extractionGC-MSResolve DOI
CalysteginesRoots and other underground partsSolvent extractionGC-MSResolve DOI
AlkaloidsLive plantsSolvent extractionUnspecifiedNo resolvable identifier
AlkaloidsLeavesSolvent extraction≥ 0.03 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
AlkaloidsLeavesSolvent extraction≤ 0.09 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
AlkaloidsRoots and other underground partsSolvent extraction≥ 0.12 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
AlkaloidsRoots and other underground partsSolvent extraction≤ 0.24 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
AlkaloidsSeedSolvent extraction0.2 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
AtropineLeavesSolvent extraction≤ 0.0467 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
AtropineSeedSolvent extraction≤ 0.0106 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
AtropineSeedSolvent extraction≥ 0.0061 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
AtropineRoots and other underground partsSolvent extraction≤ 0.2034 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
AtropineRoots and other underground partsSolvent extraction≥ 0.1044 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
AtropineLeavesSolvent extraction≥ 0.0198 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
BenzaldehydeFruit unspecifiedSolvent extractionGC-MSNo resolvable identifier
CoumarinsLive plantsSolvent extractionUnspecifiedNo resolvable identifier
EugenolFruit unspecifiedSolvent extraction1.03 PercentGC-MSNo resolvable identifier
IsoeugenolFruit unspecifiedSolvent extraction0.66 PercentGC-MSNo resolvable identifier
ScopolamineLeavesSolvent extraction≥ 5e-04 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
ScopolamineLeavesSolvent extraction≤ 0.0242 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
ScopolamineRoots and other underground partsSolvent extraction≥ 0.0062 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
ScopolamineRoots and other underground partsSolvent extraction≤ 0.0271 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
ScopolamineSeedSolvent extraction≥ 0.0023 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
ScopolamineSeedSolvent extraction≤ 0.0042 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
SystemicCardiovascular / haematologicalLeavesFreshHuman (as organism)Case reportResolve DOI
SystemicCardiovascular / haematologicalLive plantsHuman (as organism)Case reportNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Bekkouche, K., Lazrek, H.B., Jana, M. Quantitative determination of atropine and scopolamine in Mandragora from Morocco DETERMINATION QUANTITATIVE DE L'ATROPINE ET DE LA SCOPOLAMINE CHEZ LA MANDRAGORA MAROCAINE . Plantes medicinales et phytotherapie, 1993, vol. 26, no. 4, p. 309-318.
  2. Al-Khalil, Suleiman., Alkofahi, Ahmed. The chemical constituents of Mandragora autumnalis. Alexandria journal of pharmaceutical sciences, 1996, p. 135-138.
  3. Hanus, L. O., Dembitsky, V. M., Moussaieff, A. Comparative study of volatile compounds in the fresh fruits of Mandragora autumnalis . Acta chromatographica, 2006, vol. 17, p. 151-160.
  4. Bekkouche, K., Daali, Y., Cherkaoui, S., Veuthey, JL., Christen, P. Calystegine distribution in some solanaceous species. PHYTOCHEMISTRY, 2001, vol. 58, no. 3, p. 455-462. DOI
  5. Piccillo, GA., Miele, L., Mondati, E., Moro, PA., Musco, A., Forgione, A., Gasbarrini, G., Grieco, A. Anticholinergic syndrome due to 'Devil's herb': when risks come from the ancient time. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, vol. 60, no. 4, p. 492-494. DOI
  6. JIMENEZMEJIAS, ME., MONTANODIAZ, M., PARDO, FL., JIMENEZ, EC., CORDERO, MCM., GONZALEZ, MJA., DELAPUENTE, MAG. ATROPINE POISONING BY MANDRAGORA-AUTUMNALIS - REPORT OF 15 CASES. Medicina clinica, 1990, vol. 95, no. 18, p. 689-692.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue